Argenx
ARGX
#622
Rank
A$48.24 B
Marketcap
$806.85
Share price
-0.01%
Change (1 day)
-1.74%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: A$48.24 Billion

As of September 2024 Argenx has a market cap of A$48.24 Billion. This makes Argenx the world's 622th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2024

End of year Market Cap

Year Market cap Change
2024A$48.24 B45.66%
2023A$33.12 B7.55%
2022A$30.79 B21.77%
2021A$25.29 B38.99%
2020A$18.19 B85.97%
2019A$9.78 B96.67%
2018A$4.97 B93.73%
2017A$2.56 B
2014A$0.17 B

End of Day market cap according to different sources

On Sep 15th, 2024 the market cap of Argenx was reported to be:

A$48.25 Billion
by Yahoo Finance info icon info icon
A$48.25 Billion
by CompaniesMarketCap info icon info icon
A$47.76 Billion
by Nasdaq info icon info icon